Evidence map›Paper›PMID 40603767›Full record

Articlenpj metabolic health and disease2025

Comparison of polygenic risk scores for type 2 diabetes developed from different ancestry groups.

Takuma Furukawa, Megumi Hara, Yuichiro Nishida, Keitaro Tanaka, Chisato Shimanoe, Chiharu Iwasaka, Jun Otonari, Hiroaki Ikezaki, Mako Nagayoshi, Takashi Tamura and 22 more

Abstract read
In one paragraph

Article in npj metabolic health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Genetic basis of Asian diabetes.Journal of diabetes investigation · 2026
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Takuma FurukawaDepartment of Preventive Medicine, Faculty of Medicine, Saga University, Saga, Japan. sr0753@cc.saga-u.ac.jp.ORCID http://orcid.org/0000-0001-7152-5443
Megumi HaraDepartment of Preventive Medicine, Faculty of Medicine, Saga University, Saga, Japan.
Yuichiro NishidaDepartment of Preventive Medicine, Faculty of Medicine, Saga University, Saga, Japan.
Keitaro TanakaDepartment of Preventive Medicine, Faculty of Medicine, Saga University, Saga, Japan.
Chisato ShimanoeDepartment of Pharmacy, Saga University Hospital, Saga, Japan.
Chiharu IwasakaDepartment of Preventive Medicine, Faculty of Medicine, Saga University, Saga, Japan.
Jun OtonariDepartment of Psychosomatic Medicine Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Hiroaki IkezakiDepartment of Comprehensive General Internal Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka, Japan.
Mako NagayoshiDepartment of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Takashi TamuraDepartment of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yudai TamadaDepartment of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Rieko OkadaDepartment of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Isao OzeDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
Hidemi ItoDivision of Cancer Information and Control, Aichi Cancer Center Research Institute, Nagoya, Japan.
Nobuaki MichihataCancer Prevention Center, Chiba Cancer Center Research Institute, Chiba, Japan.
Yohko NakamuraCancer Prevention Center, Chiba Cancer Center Research Institute, Chiba, Japan.
Shiroh TanoueDepartment of Epidemiology and Preventive Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Chihaya KoriyamaDepartment of Epidemiology and Preventive Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Sadao SuzukiDepartment of Public Health, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Takahiro OtaniDepartment of Public Health, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Isao WatanabeDepartment of Epidemiology for Community Health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Satomi TomidaDepartment of Epidemiology for Community Health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Kiyonori KurikiLaboratory of Public Health, Division of Nutritional Sciences, School of Food and Nutritional Sciences, University of Shizuoka, Shizuoka, Japan.
Naoyuki TakashimaDepartment of Epidemiology for Community Health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Aya KadotaNCD Epidemiology Research Center, Shiga University of Medical Science, Otsu, Japan.
Masashi IshizuDepartment of Preventive Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Takeshi WatanabeDepartment of Preventive Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Masahiro NakatochiPublic Health Informatics Unit, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yukihide MomozawaLaboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Kenji WakaiDepartment of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Keitaro MatsuoDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group

Funding

Japan Society for the Promotion of Science 21K06645Japan Society for the Promotion of Science 22H04923 [CoBiA]Japan Society for the Promotion of Science 22K21086Japan Society for the Promotion of Science Innovative Areas (No. 221S0001)
6 · The paper itself

Abstract

Polygenic risk scores (PRS) are useful for assessing disease risk; however, knowledge about their effectiveness among Asian and other populations is limited. This study aimed to compare the classification accuracy of PRSs for type 2 diabetes (T2D-PRS) developed from different ancestry groups using genotype data from 14,083 Japanese participants. Participants' scores were calculated using T2D-PRS models, and logistic regression analysis and receiver operating characteristic curves were assessed. The odds ratio of diabetes per 1 standard deviation increase in PRS was 2.18 and 1.55 for the Japanese and European T2D-PRSs, respectively. The area under the curve (AUC) for the Japanese T2D-PRS was 0.781, whereas that for the European T2D-PRS was 0.738 (P < 0.001). Additionally, age-stratified analysis showed higher AUCs in younger than older age groups. The PRS developed from matched ancestry populations has high classification accuracy for diabetes and is particularly useful for the early detection of high-risk individuals with diabetes.

Identifiers

PMID40603767
PMCPMC12118717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.